Skip to main content
KKR
NYSE Finance

科尔伯格-克拉维斯-罗伯茨(KKR)和EQT据报道正在关注130亿美元的PolyPeptide收购

feedReported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$90.57
Mkt Cap
$80.748B
52W Low
$82.67
52W High
$153.87
Market data snapshot near publication time

summarizeSummary

科尔伯格-克拉维斯-罗伯茨(KKR)& Co.据报道是多家私募股权公司之一,包括EQT,在潜在的瑞士合同药物制造商PolyPeptide Group AG的收购中表示了兴趣,后者市值约为130亿美元。这一潜在的并购活动符合KKR最近的大规模资本部署,不久前该公司为其最新的美洲私募股权基金筹集了230亿美元,并推出了一个34.8亿美元的要约收购,以私有化太阳控股。虽然报告指出讨论正在进行中,交易并没有确定,但这一消息表明KKR继续对重大收购保持兴趣。交易员应该监测任何官方公告或有关潜在PolyPeptide收购的进一步细节。

在该公告发布时,KKR的交易价格为$90.57,交易所为NYSE,所属行业为Finance,市值约为$807.5亿。 52周交易区间为$82.67至$153.87。 这则新闻被评估为中性市场情绪,重要性评分为7/10。 来源:Reuters。


show_chartPrice Chart

Share this article

Copied!

feed KKR - Latest Insights

KKR
Apr 29, 2026, 2:22 PM EDT
Source: Reuters
Importance Score:
8
KKR
Apr 29, 2026, 5:03 AM EDT
Source: Reuters
Importance Score:
8
KKR
Apr 27, 2026, 5:26 PM EDT
Filing Type: DEFA14A
Importance Score:
7
KKR
Apr 24, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
7
KKR
Apr 21, 2026, 5:20 AM EDT
Source: Zawya
Importance Score:
7
KKR
Apr 14, 2026, 7:49 PM EDT
Source: Reuters
Importance Score:
8
KKR
Apr 10, 2026, 1:41 PM EDT
Source: Reuters
Importance Score:
7
KKR
Apr 02, 2026, 6:16 AM EDT
Source: Reuters
Importance Score:
9
KKR
Mar 31, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
8
KKR
Mar 31, 2026, 11:00 AM EDT
Source: EQS
Importance Score:
8